Exécution de notre outil de synthèse sur un nouvel article

Vérifiez l’article ci-dessous, puis lancez sa synthèse.


ECGGo: Design and HRV Validation of a Low-Cost ECG-Centered Multimodal Wearable Platform for Physiological Monitoring

Premchand (Indian Institute of Technology Mandi), Jayant Kalra (Indian Institute of Technology Bombay), Satyanarayanan R. Nadar (Indian Institute of Science Bangalore), Ayush Arya (Indian Institute of Technology Mandi), Sahil Sankhyan (Indian Institute of Technology Mandi), Varun Dutt (Indian Institute of Technology Mandi)

IEEE Sensors Journal
Licence : non indiquée (tous droits réservés)

Résumé : Wearable physiological monitoring outside clinical settings requires affordable, multimodal devices with sufficient accuracy for heart rate variability (HRV) assessment. Consumer photoplethysmography devices are susceptible to motion artefacts, whereas research-grade electrocardiography systems remain costly. ECGGo is an RP2040-based wearable (~USD 50 bill-of-materials) measuring electrocardiography, peripheral oxygen saturation (SpO₂), galvanic skin response, nine-axis motion, and skin-surface temperature. ECG signals are acquired at 512 Hz (18-bit) using a MAX30003 analogue front-end and processed on a smartphone using Butterworth filtering, Pan–Tompkins R-peak detection, artefact screening, and time-domain HRV extraction. Core HRV metrics (Mean NNI, SDNN, RMSSD, and SDSD) were validated against a Shimmer3 ECG system in 44 resting participants, achieving absolute errors ≤1.31 ms, Pearson correlations of 0.985–0.999, and no significant device differences. In 16 participants, resting heart rate and SpO₂ were similarly indistinguishable from a clinical pulse oximeter. The coefficient-of-variation metrics CVSD and CVNNI yielded lower correlations (r= 0.39 and 0.34, respectively), reflecting the known sensitivity of these indices to short recording epochs. In a 10-day single-subject feasibility demonstration (not a formal validation), ECGGo showed plausible day-to-day activity concordance with a Fitbit Sense 2 (r= 0.94), with multi-participant validation planned as future work. GSR, skin temperature, frequency-domain HRV, and ambulatory monitoring are implemented but not included in the present validation and are scoped as future work. The reported cost reflects the bill of materials only. ECGGo provides a practical, low-cost platform for reference-validated resting ECG-derived HRV monitoring, with multimodal sensing supporting future field-based physiological research.

Publié le 23 Sep. 2026